Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
13.14
+1.22 (10.23%)
At close: Jan 16, 2026, 4:00 PM EST
13.30
+0.16 (1.22%)
After-hours: Jan 16, 2026, 7:59 PM EST
Biohaven Stock Forecast
Stock Price Forecast
The 14 analysts that cover Biohaven stock have a consensus rating of "Buy" and an average price target of $29.43, which forecasts a 123.97% increase in the stock price over the next year. The lowest target is $9.00 and the highest is $75.
Price Target: $29.43 (+123.97%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Biohaven stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 8 | 8 | 7 | 6 | 6 |
| Buy | 7 | 7 | 7 | 5 | 4 | 4 |
| Hold | 1 | 1 | 1 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 16 | 16 | 16 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $26 → $21 | Buy | Maintains | $26 → $21 | +59.82% | Jan 6, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $11 | Hold | Reiterates | $11 | -16.29% | Dec 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $30 → $11 | Strong Buy → Hold | Downgrades | $30 → $11 | -16.29% | Dec 3, 2025 |
| UBS | UBS | Strong Buy → Hold Downgrades $26 → $11 | Strong Buy → Hold | Downgrades | $26 → $11 | -16.29% | Nov 26, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $47 → $15 | Buy | Maintains | $47 → $15 | +14.16% | Nov 20, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
19.28M
EPS This Year
-6.77
from -9.28
EPS Next Year
-3.55
from -6.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | n/a | 65.3M | ||||
| Avg | n/a | 19.3M | ||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -5.79 | -2.09 | ||||
| Avg | -6.77 | -3.55 | ||||
| Low | -7.99 | -7.71 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.